Boehringer Sees Opportunities For Jascayd In Evolving China IPF Landscape

Reimbursement The Next Step

 
• By Xu Hu
  
Healthy lungs
BI looks to reimbursement as next step for recently approved IPF drug in China (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Interviews

More from China